Sponsor pipeline

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine clinical trial pipeline

Get alerts when Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

3 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 3 with minor changes only.

  1. Minor
    3 trials marked Unknown by the registry's verification sweep

    Registry verification sweep

    Changed

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-18 NCT07827053 Clinical Study of Radiotherapy Combined With Adebrelimab and NALIRIFOX for Conversion… Phase 2 Not Yet Recruiting
2026-09-17 NCT07824232 Visual Function and Exercise in Glaucoma Patients Not Yet Recruiting

Active trials by phase

Early Phase 1
11
Phase 1
3
Phase 1/2
1
Phase 2
15
Phase 2/3
2
Phase 3
2
Phase 4
5
Not charted: 60 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 99

NCT IDTitleConditionStatusUpdated
Phase 4
NCT07675252 Efficacy and Safety of Fluticasone Propionate Nebulized Suspension for Wheezing Diseases… Acute Wheezing Disorders in Infants Aged 0 to 24 Months Not Yet Recruiting 2026-06-30
NCT07637968 Tegileridine vs Sufentanil for Postoperative Pain Management and Gastrointestinal… Postoperative Pain Not Yet Recruiting 2026-06-10
NCT07557394 A Prospective Non-randomized Controlled Interventional Study on the Effect of Shouhui… Pancreatic Cancer Not Yet Recruiting 2026-04-29
NCT07365371 A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the… Polypoidal Choroidal Vasculopathy (PCV) Not Yet Recruiting 2026-01-26
NCT06568445 Maintenance at Initial Treatment With Sequential Anti-Inflammation Reliever Therapy Bronchial Asthma Not Yet Recruiting 2024-08-23
Phase 3
NCT07414758 Golidocitinib Versus Placebo as Maintenance Therapy in PTCL Patients With Response… Peripheral T Cell Lymphoma Recruiting 2026-02-24
NCT07469046 VAH vs VA in Newly Diagnosed Elderly AML Acute Myeloid Leukemia (AML) Not Yet Recruiting 2026-04-13
Phase 2/3
NCT07389616 A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression… Peripheral T Cell Lymphoma Recruiting 2026-02-05
NCT07463313 6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced… Thymoma and Thymic Carcinoma Not Yet Recruiting 2026-03-11
Phase 2
NCT07601737 Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally… Head and Neck Squamous Cell Carcinoma Recruiting 2026-07-09
NCT07570745 Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous… Graft-Versus-Host Disease(GVHD) Recruiting 2026-05-06
NCT06832774 Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment… Prostate Cancer Metastatic Disease Recruiting 2026-03-25
NCT06483906 Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for… Acute Myeloid Leukemia Recruiting 2026-03-03
NCT06532617 Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced… Pancreatic Neoplasms Recruiting 2025-05-14
NCT06686108 Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic… T-cell Acute Lymphoblastic Leukemia Recruiting 2025-05-07
NCT06612944 Prophylactic Intervention for Relapse Prevention Post-Allogeneic Transplantation in Very… Myelodysplastic Syndromes, Adult Recruiting 2024-11-26
NCT06598722 BCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic… Lymphoblastic Lymphoma, Adult Recruiting 2024-09-24
NCT05536102 The Effectiveness and Safety of XELOX and Tislelizumab + PLD for Resectable Gastric… Gastric Cancer Recruiting 2023-03-09
NCT07827053 Clinical Study of Radiotherapy Combined With Adebrelimab and NALIRIFOX for Conversion… Pancreatic Ductal Adenocarcinoma (PDAC) Not Yet Recruiting 2026-09-18
NCT07276698 Clinical Study on Maintenance Therapy With Selinexor Combined With Azacitidine After… NK T-Cell Lymphoma Not Yet Recruiting 2025-12-11
NCT07276737 Preconditioning With a Combination of Thiotepa, Cyclophosphamide, and Busulfan for… NK T-Cell Lymphoma Not Yet Recruiting 2025-12-11
NCT07236645 Efficacy and Safety of Ginkgo Biloba Extract EGb761® in Patients With Diabetic Retinopathy Non-proliferative Diabetic Retinopathy (NPDR) Not Yet Recruiting 2025-11-19
NCT07142863 Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable… Osteosarcoma Not Yet Recruiting 2025-08-27
NCT06754540 Azacitidine Combined with Donor Lymphocyte Infusion for Acute Myeloid Leukemia… Acute Myeloid Leukemia (AML) Not Yet Recruiting 2025-01-17
Phase 1/2
NCT07398612 Safety and Efficacy of Human Adipose-Derived Stem Cell Exosomes in Acute Ischemic Stroke Acute Ischemic Stroke Not Yet Recruiting 2026-02-10
See all 99 active Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine trials with filters →

Disease areas by active trials, top 10 of 27

Leukemia (10) · Pancreatic Cancer (10) · Non-Hodgkin Lymphoma (8) · Acute Myeloid Leukemia (AML) (7) · Prostate Cancer (6) · Lung Cancer (4) · Acute Lymphoblastic Leukemia (ALL) (3) · Non-Small Cell Lung Cancer (NSCLC) (3) · Asthma (2) · Colorectal Cancer (2)

Get alerts when Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free